ArborGen Holdings Limited logo

Rubicon Announces CEO Appointment

Director Appointment13 September 2019ARBIndustrials

www.rubicon-nz.com



Rubicon Announces CEO Appointment




13 September 2019 – Rubicon’s Chairman, Dave Knott, announced the appointment of Andrew Baum

as the CEO of the Rubicon Group.

Andrew joined Rubicon’s subsidiary ArborGen Inc in March 2012 as president and chief executive

officer. During Mr Baum’s 30-year career in the technology industry, he has served as the president

and chief executive officer of Sembiosys Genetics Inc, taking the company from a university-based

research initiative to a fully integrated, publicly traded biotechnology. His career has also included

working in increasing levels of responsibility for Calgene, Inc, becoming president of the oils division

in 1992. Following Calgene’s sale to Monsanto, he served as the director of business development,

sustainable development sector.

Andrew has a BS in Industrial Engineering and Operations Research from the University of California,

Berkeley.


END

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.